Clinical Ink: acquisition by GI Partners
Private investment outfit GI Partners has sealed the deal on its acquisition of trial technology specialists Clinical Ink. Based in Horsham, Penn., Clinical Ink offers a range of data-focused solutions for clinical trials, including its Lumenis eSource suite.
Working closely with Clinical Ink’s senior management, GI Partners plans to support acceleration of the company’s innovation regarding its clinical trial workflow technologies. Existing shareholder NovaQuest reportedly will continue serving as a minority investor.
